NEW YORK, Feb. 5, 2026 /PRNewswire/ — LifeZoom, a natural-restorative brand, today launches Oclux, a red light eye mask that expands the company’s red light product lineup. Positioned as a holistic solution that balances visual aesthetics, user experience, and daily rhythms, Oclux is designed to help relieve the physical and mental imbalances associated with modern lifestyles and to guide users back toward a more instinctive state of rest.

Designed under the direction of LifeZoom’s core designer Evan Cole, Oclux is now available through LifeZoom’s Amazon store and brand website for USD 149.

Function as a Support for Natural Balance

Oclux uses red light to gently counteract the disruptions caused by prolonged screen exposure. With 48 high-efficiency LEDs and two modes, it brings restorative care into daily life without adding burden.

• Sleep Mode • Restore Rhythm Shaped by Nature

Sleep Mode uses 660 nm red light to mimic sunset, helping regulate circadian rhythm and melatonin.^[1] Red light may improve sleep quality and shorten sleep onset,^[2] 850 nm near-infrared may relax the sympathetic system and support deep sleep.^[3] It may also boost collagen for smoother eye-area skin.^[4] By addressing screen-related circadian disruption, Sleep Mode helps users relax and rest more deeply.

• Eye Comfort Mode • Repair Life Shaped by the Screen

Eye Care Mode uses 660 nm red light to support microcirculation, mitochondrial activity, and cell repair.^[5] It may reduce eye dryness, fatigue, and periocular nerve tension; regular use may improve eye comfort after screen exposure.^[6]

Aesthetics as Part of the Therapeutic Effect

“LifeZoom never shies away from talking about aesthetics in the pursuit of health—in fact, we talk a lot,” said Cole.

Oclux uses gentle materials designed with sensitive users in mind. Its soft, anti-fingerprint shell is easy to clean and streak-free. A patterned, selectively light-permeable surface allows red light to shine through, enhancing the ambiance of each session. The sliding-buckle head strap is quieter and more durable than Velcro, while the lightweight, ergonomic form follows head contours for long-wear comfort and portability. Together, these details create a refined and pleasing aesthetic in use.

Light to Restore, Light to Go

Built-in timer and memory functions automatically recall the most recent time and intensity settings, allowing daily care to remain simple and intuitive. With just a few simple steps, users can activate the device, close their eyes, and let Oclux—alongside aromatherapy, music, or a quiet environment—complete the session.

“Whether it’s a bedroom filled with the scent of essential oils or a park where you can smell fresh grass, both can become part of a red light routine,” said Evan Cole. “Users choose the setting, and we make those settings possible.” Oclux supports power-bank operation, and combined with its lightweight design, restorative care is no longer limited by proximity to a wall outlet. Users’ attention to health is free to extend beyond the bedroom and into daily life.

“Oclux itself is a design experiment in making restorative care easier to happen,” Evan Cole concluded. “From wearability and daily rhythm to portable use cases, it does not require users to change their lifestyles—it adapts to real modern rhythms. At LifeZoom, we want health to be no extra burden, but to return to daily life in a more natural, more welcomed way.”

About LifeZoom

LifeZoom is a wellness brand focused on integrating thoughtful design, evolving technology, and real user insights into everyday well-being. Guided by a belief that health should feel intuitive rather than demanding, the brand develops solutions that support both physical balance and mental restoration. Through continuous exploration and refinement, LifeZoom is committed to helping individuals place well-being at the center of daily life in a more natural and sustainable way.

Media Contact
Joey
marketing@lifezoom.tech

References

1.Cajochen, C., et al. (2005). Role of light in the regulation of circadian rhythms and sleep. Journal of Biological Rhythms, 20(4), 305–314.

2.van der Lely, S., et al. (2015). Blue blocker glasses as a countermeasure for alerting effects of evening LED screen exposure. Journal of Adolescent Health, 56(1), 113–119.

3.Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337–361.

4.Avci, P., et al. (2013). Low-level light therapy for skin rejuvenation. Seminars in Cutaneous Medicine and Surgery, 32(1), 41–52.

5.Karu, T. I. (2010). Mitochondrial mechanisms of photobiomodulation. Photomedicine and Laser Surgery, 28(2), 159–168.

6.Eells, J. T., et al. (2004). Mitochondrial signaling in the retina and optic nerve. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 101(7), 2391–2396.

YIWU, China, Feb. 5, 2026 /PRNewswire/ — A news report from Yiwu Media Convergence Center:

On February 4th, the 2026 Spring Festival Gala Cultural Pop-up Store at the Yiwu Centre shopping district was bustling with crowds. Inside, a dazzling array of creative products filled the space, including brocade bags featuring Yiwu’s “Six Virtues” culture, red envelopes printed with poems by the Tang Dynasty poet Luo Binwang, and the Year of the Horse “Spring Bowl” gift sets. Stepping into the store, you’ll see Spring Festival elements blended with creative design, all centered around the theme of the Year of the Horse.

It is known that the five Spring Festival Gala pop-up stores making their debut this time are not only new cultural scenes themed around the Spring Festival Gala but also eye-catching check-in spots for cities celebrating the Chinese New Year. The five stores are strategically located in Yiwu’s core business districts, transportation hubs, and vibrant night market, covering two major commercial landmarks—Yiwu Centre and Yiwu Place, two key transportation gateways—Yiwu Airport and Yiwu Railway Station, as well as Santing Road Night Market, a “landmark of urban life and atmosphere”.

“These cultural and creative products not only have a Yiwu flair but are also very stylish, making them perfect for both gifts and personal use,” said a Tunisian merchant at the Yiwu Centre pop-up store, who had specially brought friends for shopping. “This is for Chinese New Year, right? It’s so beautiful!” remarked a Colombian visitor on-site with genuine admiration.

The pop-up stores adopt a combined model of “products exhibition and sales + postal services”. They not only offer 17 limited-edition collaborative products for the Year of the Horse but also provide convenient services such as sending New Year-themed stamps and mailing products. This allows residents and visitors to effortlessly “take the festive atmosphere of the New Year home” while shopping, traveling, or exploring night markets.

Following this, each pop-up store will launch interactive activities such as intangible cultural heritage experiences and hand-written “Fu” (fortune) characters. These initiatives will deeply blend the cultural charm of the Year of the Horse with the vibrant urban atmosphere, building momentum for the Spring Festival Gala sub-venue.

KITCHENER, ON, Feb. 5, 2026 /PRNewswire/ — Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) today announced that e-STORAGE, its energy storage solutions business, and Sunraycer, a leading developer, owner, and operator of clean energy power sites, have entered into agreements for the supply and long-term servicing of two standalone battery energy storage projects totaling 503 MWh DC in Franklin County, Texas.

The projects, collectively referred to as the Lupinus projects, are being developed by Sunraycer. They comprise Lupinus 1, a 202 MWh facility expected to begin construction in Q1 2027 and reach commercial operation in Q3 2027, and Lupinus 2, a 301 MWh facility scheduled to start construction in Q3 2026 and achieve commercial operation in Q2 2027.

Under the agreements, e-STORAGE will deliver its SolBank 3.0 battery energy storage system and provide 10 years of long-term services, supporting system reliability, performance optimization, and availability throughout the project lifecycle. The battery cells integrated into SolBank 3.0 are manufactured within Canadian Solar’s global manufacturing network, reinforcing supply chain resilience and long-term operational reliability at scale.

The Lupinus projects will play a vital role in supporting renewable energy integration and enhancing grid stability within the ERCOT market, one of North America’s fastest-growing and most dynamic energy storage markets. This collaboration reflects both companies’ shared commitment to deploying secure, scalable, and efficient energy storage solutions that enable a more flexible and resilient power grid.

David Lillefloren, CEO of Sunraycer, said: “Partnering with e-STORAGE on the Lupinus projects represents a significant step forward in Sunraycer’s mission to advance sustainable energy infrastructure across Texas and beyond. These projects both strengthen the reliability of the ERCOT grid and underscore the critical role of battery storage in supporting the clean energy transition. Together with e-STORAGE, we’re delivering long-term value to our communities and customers in Texas.”

Colin Parkin, President of Canadian Solar and President of e-STORAGE, said: “We are pleased to partner with Sunraycer on the Lupinus projects in Texas. Building on our established collaboration, these systems will leverage our BESS technology and service platform to deliver long-term operational value and support the continued growth of reliable, utility-scale energy storage infrastructure across Texas.”

About Canadian Solar Inc.

Canadian Solar is one of the world’s largest solar technology and renewable energy companies. Founded in 2001 and headquartered in Kitchener, Ontario, the Company is a leading manufacturer of solar photovoltaic modules; provider of solar energy and battery energy storage solutions; and developer, owner, and operator of utility-scale solar power and battery energy storage projects. Over the past 24 years, Canadian Solar has successfully delivered nearly 170 GW of premium-quality, solar photovoltaic modules to customers across the world. Through its subsidiary e-STORAGE, Canadian Solar has shipped over 16 GWh of battery energy storage solutions to global markets as of September 30, 2025, boasting a $3.1 billion contracted backlog as of October 31, 2025. Since entering the project development business in 2010, Canadian Solar has developed, built, and connected approximately 12 GWp of solar power projects and 6 GWh of battery energy storage projects globally. Its geographically diversified project development pipeline includes 25 GWp of solar and 81 GWh of battery energy storage capacity in various stages of development. Canadian Solar is one of the most bankable companies in the solar and renewable energy industry, having been publicly listed on the NASDAQ since 2006. For additional information about the Company, follow Canadian Solar on LinkedIn or visit www.canadiansolar.com.

About e-STORAGE

e-STORAGE is a subsidiary of Canadian Solar and a leading company specializing in designing, manufacturing, and integrating battery energy storage systems for utility-scale applications. e-STORAGE offers proprietary battery energy storage solutions, comprehensive EPC services, and innovative solutions aimed at improving grid operations. Currently, e-STORAGE operates fully automated, state-of-the-art manufacturing facilities with an annual battery energy storage system capacity of 15 GWh and battery cell capacity of 3 GWh, on a single-shift and double-shift annualized basis, respectively. For more info, please refer to the Media&PR section of www.csestorage.com and follow our LinkedIn page.

About Sunraycer

Sunraycer, a Crayhill Capital Management portfolio company, is a rapidly-growing, Annapolis, Maryland-based renewable energy platform that has a development and construction stage pipeline of approximately 2 GW of solar and 2 GW of BESS utility-scale power plants. Sunraycer provides pre-NTP and acquisition capital to developers involved in all types of renewable energy endeavors. Its goal is to streamline the complexities of development and eliminate financing challenges for the developer community. Sunraycer leverages enterprise-scale partnerships with proven industry leaders, as well as an experienced and driven in-house team of renewable energy experts, to accelerate the deployment of development-stage projects. For more information, please visit Sunraycer’s website at https://sunraycer.com/ or follow Sunraycer on LinkedIn for the latest company news and events.

Safe Harbor/Forward-Looking Statements

Certain statements in this press release, including those regarding the Company’s expected future shipment volumes, revenues, gross margins, and project sales are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially. These statements are made under the “Safe Harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by such terms as “may”, “will”, “expect”, “anticipate”, “future”, “ongoing”, “continue”, “intend”, “plan”, “potential”, “prospect”, “guidance”, “believe”, “estimate”, “is/are likely to” or similar expressions, the negative of these terms, or other comparable terminology. These forward-looking statements include, among other things, our expectations regarding global electricity demand and the adoption of solar and battery energy storage technologies; our growth strategies, future business performance, and financial condition; our transition to a long-term owner and operator of clean energy assets and expansion of project pipelines; our ability to monetize project portfolios, manage supply chain fluctuations, and respond to economic factors such as inflation and interest rates; our outlook on government incentives, trade measures, regulatory developments, and geopolitical risks; our expectations for project timelines, costs, and returns; competitive dynamics in solar and storage markets; our ability to execute supply chain, manufacturing, and operational initiatives; access to capital, debt obligations, and covenant compliance; relationships with key suppliers and customers; technological advancement and product quality; and risks related to intellectual property, litigation, and compliance with environmental and sustainability regulations. Other risks were described in the Company’s filings with the Securities and Exchange Commission, including its annual report on Form 20-F filed on April 30, 2025. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. Investors should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and Canadian Solar undertakes no duty to update such information, except as required under applicable law.

Canadian Solar Inc. Investor Relations Contact

Wina Huang
Investor Relations
Canadian Solar Inc.
investor@canadiansolar.com

e-STORAGE MEDIA CONTACT
marketing@csisolar.com 

Sunraycer Media Inquiries
Jake Forrestal
Prosek Partners
pro-crayhill@prosek.com

CHANGZHOU, China, Feb. 5, 2026 /PRNewswire/ — Jin Medical International Ltd. (NASDAQ:ZJYL) (“Jin Medical”, and together with all its subsidiaries, the “Company”), a NASDAQ-listed leading provider of rehabilitation medical equipment hosted a CEO Fireside Chat on February 2, 2026 where the CEO shared some insights into the Company’s recent strategic priorities and long-term growth considerations.

The following questions were prepared by the Company and addressed by the Company’s CEO, Dr. Erqi Wang during the conversation. Certain statements made during the discussion were forward-looking, and the Company provided a cautionary note regarding forward-looking statements prior to the start of the conversation.

1. Reverse Split

Question： At Jin Medical’s recent extraordinary general meeting, shareholders were asked to approve a proposal authorizing the Company’s board of directors to implement future reverse stock splits at specified ratios. Many investors view reverse splits as a compliance-driven move. What’s your views on that?

Dr. Wang： I have observed reverse splits being often associated with compliance considerations, and we don’t shy away from that reality.

In addition to potentially enabling us to regain compliance with Nasdaq’s continuing listing standards, we view the reverse split as a strategic reset point. We hope that It will allow us to realign our capital structure with the Company’s long-term fundamentals and improve market perception about our competitiveness. We hope it can be something more than just short-term price mechanics.

2. Strategic Plan to Long-Term Value Creation

Question: How is management thinking about the Company’s priorities going forward, particularly in terms of execution, resource allocation and short-term and long-term operational focus? 

Dr. Wang:  Going forward, there are a few things in our priorities.

First, clear and consistent market communication. We intend to communicate our progress more frequently based on strategic and development goals and operational milestones, rather than short-term narratives.

Second, disciplined capital allocation. Our priority is to invest in manufacturing capability, product certification, and market expansion where we believe the return potential is strong, while maintaining prudent balance sheet management.

Third, we take a long-term oriented perspective and we plan to actively communicate that perspective to our shareholders — recognizing the industry cycle, the scale and duration of our manufacturing investments, and the time required to scale regulated medical products.

3. 2026–2027 Outlook

Question: Looking ahead to 2026 and 2027, can you share managements’ current primary objectives?

Dr. Wang:   Our 2026-2027 objectives are driven by three goals:

• Broader commercialization following product certifications
• Manufacturing scale-up and cost normalization
• Expansion into regional and international markets

Underlying our assumptions is a disciplined approach to growth — prioritizing returns that we believe are repeatable and strengthen our operational stability over pursuing rapid growth that may be inconsistent or unsustainable.

4. Operating Leverage

Question: How should investors think about operating leverage? Where do you see the greatest opportunities to improve efficiency?

Dr. Wang: The most significant opportunities lie in manufacturing efficiency, supply chain integration, and product mix optimization. As fixed costs are absorbed across higher volumes and automation improves consistency, we believe margins can expand in a disciplined and sustainable manner.

5. Chuzhou New Factory – Strategic Importance

Questions: The Chuzhou new factory is a major investment for Jin Medical. Can you walk us through its strategic role — in terms of capacity expansion, cost structure, automation, and long-term competitiveness?

Dr. Wang: The Chuzhou facility is a cornerstone of our long-term manufacturing strategy. It is expected to launch full capacity production by the end of April 2026.

It is designed to support scalable capacity, improved automation, and tighter quality control. Over time, we believe it will lower unit costs, enhance production flexibility, and strengthen our ability to serve both domestic and international markets competitively.

6. Chuzhou Factory Timeline

Question: What is the expected timeline for ramp-up at the Chuzhou facility?

Dr. Wang: The ramp-up will be gradual and disciplined. Initial production will focus on selected product lines, followed by broader capacity utilization.

7. Industry Outlook

Question: From your perspective, how do you see the industry evolving over the next three to five years?

Dr. Wang: Over the next three to five years, we see strong structural demand driven by aging populations, rehabilitation needs, and rising healthcare quality expectations.

At the same time, the industry is moving toward higher standards in compliance, manufacturing, and technology integration — areas where scale, execution, and discipline matter.

8. US–China Relations & Risk Management

Question：US–China relations remain an important variable for global manufacturing companies. How does management assess the potential impact on Jin Medical, and what steps are being taken to manage geopolitical and supply chain risks?

Dr. Wang： We view geopolitical risk as a factor to be managed.

Our approach focuses on supply chain diversification, regional manufacturing flexibility, and regulatory compliance across markets. We believe these steps help ensure resilience regardless of external policy changes.

About Jin Medical International Ltd.

Founded in 2006 and headquartered at Changzhou, Jiangsu Province of China, Jin Medical designs, develops, manufactures and markets wheelchairs and living aids products for people with disabilities, elderlies, and for rehabilitation application. Currently, Jin Medical already operates two manufacturing plants of approximately 230,000 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. Jin Medical is currently establishing a new facility with 430,000 square feet in Chuzhou, Anhui Province, China. Jin Medical works with more than 40 distributors in China and more than 20 international distributors. The majority of Jin Medical’s wheelchair products, with more than 30 models, are sold to distributors in Japan and China. Jin Medical continuously delivers innovative wheelchair products that are both lightweight and ergonomic. For more information, please visit: http://www.jinmed.com.

Forward-Looking Statement

This press release contains certain forward-looking statements made during the CEO Fireside Chat as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may”, “will”, “should”, “intend”, “plan”, “strive”,  “believe”, “expect”, “anticipate”, “project”, “estimate,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company’s ability to achieve its goals and strategies, the Company’s future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, import and export restrictions, fluctuations in general economic and business conditions, industry trend and outlook, geopolitical relations and challenges and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

ir@jinmed.com